Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
2
×
boston top stories
clinical trials
fda
hepatitis b
2
×
life sciences
national blog main
national top stories
alexion pharmaceuticals
aligos therapeutics
alnylam pharmaceuticals
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
boehringer ingelheim
cavion
cephalgia
chronic hepatitis b virus
david goldstein
deals
demodex blepharitis
depression
dicerna pharamceuticals
epilepsy
essential tremor
eventide asset management
hepatitis b virus
hereditary transthyretin amyloidosis
horowitz group
isoxazolines
jazz pharmaceuticals
kiran reddy
lotilaner
madrigal pharmaceuticals
major depressive disorder
neuroscience
What
medicines
research
2
×
biotechs
caught
causing
central
cns
dicerna
disease
disorder
drug
drugs
emerged
eye
gene
hepatitis
intended
ipos
kept
leads
nervous
pay
pharma
pharmaceuticals
praxis
precision
prep
producing
protein
quiet
roche
stealth
stop
team
way
Language
unset
Current search:
" boston blog main "
×
research
×
" hepatitis b "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
